These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    Author: Centers for Disease Control and Prevention (CDC).
    Journal: MMWR Morb Mortal Wkly Rep; 1997 Sep 05; 46(35):813-5. PubMed ID: 9310213.
    Abstract:
    Staphylococcus aureus is one of the most common causes of both hospital- and community-acquired infection worldwide. Since the emergence of methicillin-resistant S. aureus (MRSA) in the 1980s in the United States, vancomycin has been the antimicrobial agent of choice for serious MRSA infections. S. aureus with reduced susceptibility to vancomycin (minimum inhibitory concentration [MIC]=8 micro/mL) was first reported to have caused infection in a patient in Japan in May 1996. In August 1997, the first S. aureus isolate intermediately resistant to vancomycin (VISA; MIC=8 micro/mL) in the United States was reported in Michigan. This report updates the ongoing investigation in Michigan and describes preliminary findings of the ongoing investigation of a second case of VISA infection in a patient in New Jersey.
    [Abstract] [Full Text] [Related] [New Search]